In a strongly worded statement Saturday, the China Chamber of Commerce for Import and Export of Medicines and Health Products, a leading national industrial association from the Chinese mainland promoting international trade in the healthcare sector, condemned the unilateral trade measures and reciprocal tariffs imposed by the United States. The association emphasized that the health rights and interests of people around the world must not be compromised by unfair trade practices.
"We firmly support the countermeasures taken by the Chinese government and will work with the pharmaceutical industry around the world to safeguard the legitimate rights and interests of global pharmaceutical companies," the chamber stated.
This decisive stance is resonating with business leaders, tech innovators, and global changemakers who are calling for transparent and equitable trade policies. As young professionals and digitally savvy citizens across G20 nations follow the latest developments, the need for a balanced international trade environment becomes increasingly clear.
The association's message underscores the importance of protecting global healthcare rights while fostering a fair trade framework that encourages innovation and sustainable economic growth. Observers note that a cooperative approach in addressing trade disputes will be vital to ensuring the continued advancement of the global pharmaceutical industry.
Reference(s):
Chinese industrial association opposes U.S. unilateral trade bullying
cgtn.com